Home Ed. 2019 May Home BP monitoring encouraged amid rising hypertension incidence in PH

Home BP monitoring encouraged amid rising hypertension incidence in PH

OMRON, Philippine Society of Hypertension and the Philippine Heart Association underscore the importance of home BP monitoring in this year’s May Measurement Month

Despite high awareness among Filipinos about hypertension and its complications, high blood pressure remains a leading cause of death locally, earning it the moniker public enemy number 1.

About 120,000 Filipinos die annually, directly and indirectly, due to hypertension-related complications. The data from May Measurement Month 2017 placed the hypertension prevalence rate in the country at 34 percent.

In a bid to combat the steady increase in the number of hypertension cases in the country, OMRON Healthcare Philippines joins the Philippine Society of Hypertension (PSH), the Philippine Heart Association (PHA) and other health partners in campaigning for Home Blood Pressure Monitoring (HBPM) as a key mitigation activity against hypertension and its complications. 

“Hypertension is a risk factor of heart and cardiovascular diseases.  People of all age groups need to be made aware of hypertension dangers and its prevention, among others doing self-measurement of blood pressure at home. OMRON Healthcare Philippines continues to work diligently with various health organizations to help address the country’s worsening hypertension problem by offering reliable and easy-to-use healthcare equipment that help users monitor their health better. We are glad that we get to campaign for HBPM alongside PSH and PHA. We hope that together with our global Generation Zero campaign, which aims to eliminate cardiac events, we can look forward to a healthier future for everyone.” shares OMRON Healthcare Regional Head Mr. Yoshiaki Nishiyabu.


With hypertension being asymptomatic, many are not aware that they have hypertension.  Hypertension is often called the “silent killer” and one effective way to detect it early is through daily self-monitoring of blood pressure at home. Performing self-monitoring within the comfort of one’s home tremendously helps patients feel more relaxed as they are surrounded by familiar environment, thus leading to more accurate readings. Moreover, home blood pressure monitoring allows detection of irregularity in blood pressure readings through efficient data tracking.

Home blood pressure monitoring can easily be adopted and practiced by anyone, whether living in the urban or rural areas and belonging to any age group. Besides, performing regular home blood pressure monitoring is actually a cost-effective solution in the long run compared with frequent trips to the doctor or hospital.

The International Society of Hypertension (ISH) stresses the importance of regular screening to prevent the complications caused by hypertension. To further this cause, ISH launched the May Measurement Month initiative.

“May Measurement Month puts the spotlight on increasing access to blood pressure screening as potentially the most effective way to reduce hypertension’s adverse effect on health,” says Prof. Alta E. Schutte, president of ISH.


May Measurement Month (MMM) is an annual global public screening campaign spearheaded by ISH and the World Hypertension League. MMM aims to raise awareness about the risks and issues posed by hypertension.

Locally, PSH leads the rollout of the campaign. The Philippines ranked first in terms of total screened individuals when the campaign was launched in the country last May 2017, with a total of 272,000 individuals screened or 22 percent of the global pooled data of 1.2 million for that year.

“We aim to increase BP awareness to 80 percent, treatment rate to 60 percent and a control rate of 30 percent by 2022. At such rates, we are optimistic that we can reduce BP-related deaths by 25 percent and save about 30,000 Filipinos yearly. Through campaigns such as the May Measurement Month, we can further raise awareness about the importance of BP screening and other methods such as home BP monitoring, which are vital to averting hypertension complications,” notes Dr. Leilani B. Mercado-Asis, president of PSH.

This year, 20 government and non-government agencies will carry out the nationwide BP screening and counselling campaign. Dr. Alejandro F. Diaz, country lead of MMM 2019, is fervent on screening 300,000 Filipinos, with OMRON Healthcare Philippines as its official equipment partner. The OMRON digital BP monitoring devices are the only ones in the country to be clinically validated by PSH for accuracy and precision.

Since its start in 2017, OMRON Healthcare Philippines has donated a total of 4,500 digital BP monitoring devices, measuring the blood pressure of more than 400,000 Filipinos. In the 2019 rollout of MMM, the company is donating 1,000 state-of-the-art digital blood pressure monitoring devices.

May Measurement Month is in line with Presidential Proclamation 1761, which was enacted on May 1, 2009 by then President Gloria Macapagal Arroyo and declared the month of May as Hypertension Awareness Month. This enjoins government and nongovernment organizations to be major collaborators in implementing BP awareness and control programs in the country. In celebration of MMM, OMRON, PSH and PHA encourage Filipinos to proactively take all measures possible, HBPM among them, to mitigate the risks brought by hypertension.

For more information on May Measurement Month, you may visit www.maymeasure.com.

Photo above shows Philippine Society of Hypertension (PSH) Treasurer Dr. Gilbert Vilela, May Measurement Month 2019 Country Lead Dr. Alejandro Diaz, Philippine Heart Association (PHA) Chair – Hypertension Council Dr. Lourdes Bunyi, PHA President Dr. Nanette Rey, PSH President Dr. Leilani Mercado-Asis, OMRON Philippines Country Head Antoinette Gutierrez and OMRON Philippines Marketing Manager Janis Calaqui reaffirm commitment to help reduce hypertension prevalence in the Philippines


CARE Co., Ltd.

Committed to improving people’s lives, OMRON HEALTHCARE provides clinically proven, innovative medical equipment for health monitoring and therapy. Our product portfolio includes blood pressure monitors, nebulizers, electronic thermometers, blood glucose monitors and activity counters as well as body composition monitors and professional medical devices. For many decades, OMRON’s devices have helped people prevent, treat and manage lifestyle diseases both at home and in clinical practice in more than 100 countries in the world. OMRON HEALTHCARE Group is headquartered in Muko City, Kyoto Prefecture, Japan.

Photo above shows (L-R) Philippine Society of Hypertension President Dr. Leilani Mercado-Asis, Philippine Heart Association President Dr. Nanette Rey and OMRON Philippines Country Head Antoinette Gutierrez during the symbolic blood pressure monitoring activity held at the May Measurement Month 2019 media launch.